REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Duchembio Co. Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Duchembio Co. Ltd. Profile Updated: January 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the provision of functional food and medicines. The Company is involved in the manufacture and distribution of radiopharmaceuticals and medical equipment. The Company was founded on March 1, 2003 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on December 29,2014.

Headquarters
4F, 47, Kyonggidae-Ro, Seodaemun-Gu
Seoul; Seoul;

Contact Details: Purchase the Duchembio Co. Ltd. report to view the information.

Website: http://duchem.rootshell.co.kr

Basic Information
Total Employees:
Purchase the Duchembio Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Duchembio Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Duchembio Co. Ltd. report to view the information.
Incorporation Date:
2003
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Subsidiaries
Khealth Corporation
Company Performance
Financial values in the chart are available after Duchembio Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
7.01%▲
Total operating revenue
4.06%▲
Operating profit (EBIT)
780.21%▲
EBITDA
12.71%▲
Net Profit (Loss) for the Period
N/A
Total assets
-4.04%▼
Total equity
23.87%▲
Operating Profit Margin (ROS)
13.23%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-54.29%▼
Quick Ratio
0.11%▲
Cash Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo